[Market Focus] Neofit Soars After Being Named Among "World's Top HealthTech Companies"

As of 10:00 a.m. on September 22, shares of Neofit on the KOSDAQ market were trading at 19,190 won, up 16.02% from the previous day's closing price. This surge appears to be driven by the news that the company was included in Time magazine's list of the "World's Top HealthTech Companies."

Neofit develops solutions for the diagnosis and treatment planning of brain diseases, as well as medical devices for treatment, using deep learning-based brain imaging analysis technology. In particular, Neofit focuses on neurodegenerative brain diseases, including Alzheimer's disease.

Previously, Time announced its ranking of the "World's Top HealthTech Companies of 2025," based on three criteria: financial performance, reputation analysis, and online engagement.

Among domestic companies, Neofit was selected in the diagnostics category. In the health information and management category, Kakao Healthcare, Cenacle Soft, and EZCaretech were recognized. In the artificial intelligence (AI) and data analytics category, AITRICS and Medipixel were included. Olive Healthcare was chosen in the medical devices and wearables category, while HealthConnect was selected for the telemedicine and treatment category.

This content was produced with the assistance of AI translation services.